GlassScriptPhysician profile
Tim C Kisabeth
NPI 1851384796
$4,657.11
in general payments reported to CMS, 2019-2025
40 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $192 · 2021: $723 · 2022: $645 · 2023: $844 · 2024: $941 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,829.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $758.55 | 2019-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $560.37 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $425.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $339.52 | 2020-2025 | Freestyle Libre 3 |
| Abbvie INC. | $285.11 | 2019-2025 | |
| Corcept Therapeutics | $242.37 | 2023-2025 | Korlym |
| Amarin Pharma, INC. | $220.90 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $168.42 | 2021-2023 | |
| Astellas Pharma US INC | $159.55 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $147.61 | 2020-2024 | Slynd |
| Astrazeneca Pharmaceuticals LP | $141.89 | 2020-2025 | Farxiga, Airsupra, Breztri |
| Organon LLC | $107.32 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $101.75 | 2021-2025 | |
| Agile Therapeutics, INC. | $92.81 | 2021-2024 | Twirla |
| Janssen Pharmaceuticals, INC | $90.26 | 2021-2024 | Xarelto |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Kisabeth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.